PMID: 11917293Mar 28, 2002Paper

Preclinical modeling of improved amifostine (Ethyol) use in radiation therapy

Seminars in Radiation Oncology
David R CassattMark S Hanson

Abstract

Amifostine (Ethyol) has been evaluated clinically as a radioprotective agent for the prevention of xerostomia and mucositis for patients receiving radiotherapy (RT). Currently, amifostine is approved for the prevention of xerostomia in head and neck cancer patients receiving RT when administered intravenously (IV) before RT. For the clinician, there would be several advantages to administering the drug subcutaneously and to being able to show its protective effects on mucositis. The authors have developed a rat RT model to examine the protective effects of amifostine after IV and subcutaneous (SC) administration in a mucositis model. Rats (5 per group) were given 200 mg/kg (human dose equivalent of approximately 1,300 mg/m(2)) of amifostine either IV or SC, and their head and neck regions were exposed to 15.3 Gy of gamma radiation 0.5, 2, 4, and 8 hours after amifostine administration. For 10 days after treatment, the oral cavities of the rats were examined for signs of mucositis. Mucosal erythema and mucosal edema were scored according to 0 through 5 and 0 through 2 scales, respectively, with the scores added to indicate overall mucositis. The average mucositis score for the untreated animals was 3.5. Rats were protected from ...Continue Reading

Citations

Apr 18, 2003·Cancer Immunology, Immunotherapy : CII·Paul ChinnNabil Hanna
Sep 1, 2005·Basic & Clinical Pharmacology & Toxicology·Süreyya BarunZeynep Sevim Ercan
Feb 18, 2010·Science Translational Medicine·Justin B MaxhimerDavid D Roberts
Dec 23, 2009·Cancer Biotherapy & Radiopharmaceuticals·Seyed Jalal Hosseinimehr
Jul 19, 2011·American Journal of Physiology. Lung Cellular and Molecular Physiology·Yasuhiro TerasakiYuh Fukuda
Oct 22, 2011·Radiation Research·Pankaj K SinghVijay K Singh
Dec 18, 2013·Dalton Transactions : an International Journal of Inorganic Chemistry·Shiv Shankar PaulKalyan K Mukherjea
Feb 18, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Kai WangYong-Xue Liu
May 28, 2018·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Huijun ZhangDaoben Hua
Aug 25, 2004·The Journal of Pharmacy and Pharmacology·Sarala PamujulaTarun K Mandal
Mar 3, 2004·Bone Marrow Transplantation·G FacorroG Kusminsky
Sep 26, 2013·The Journal of Pharmacology and Experimental Therapeutics·Takako NakashimaTatsuhiro Ishida
Sep 25, 2020·International Journal of Radiation Biology·Fatemeh AmaniMohammad Hossein Mohammadi
Apr 28, 2012·Free Radical Research·Yunhai ChuaiJianming Cai
Oct 17, 2013·Chemistry & Biodiversity·Vesna S KuntićSnežana M Uskoković-Marković
Nov 23, 2017·Environmental Health and Preventive Medicine·Feng WangHaibo Wang
Jul 16, 2005·International Journal of Radiation Biology·S PamujulaT K Mandal
Apr 8, 2021·ACS Biomaterials Science & Engineering·Yahong LiuHongqi Tian
Jan 12, 2019·International Journal of Biological Macromolecules·Subharthi BanerjeeKalyan K Mukherjea
Aug 9, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Qiongge HuAnwen Shao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.